Sirj Goswami

Sirj Goswami, PhD, is the CEO and Co-founder of InsightRX, a company focused on enhancing therapeutic outcomes through precision medicine. He has a strong background in pharmacogenomics and pharmacometrics, with a PhD from the University of California, San Francisco (UCSF), where his research concentrated on developing methodologies to optimize diabetes treatment based on genetic variants.124

Professional Background

• InsightRX: Founded in 2015, InsightRX provides a cloud-based platform that utilizes quantitative pharmacology and artificial intelligence to guide precision dosing in healthcare settings.13
• Previous Experience: Before founding InsightRX, Sirj worked at Genentech and Pfizer, where he contributed to clinical pharmacology and drug development. He also served as an FDA fellow during his studies at UCSF.245
• Academic Role: In addition to his entrepreneurial endeavors, he is an adjunct professor at UCSF, teaching applications of quantitative pharmacology for precision medicine.2

Contributions and Recognition

Sirj has been actively involved in the precision dosing community, serving as its first chair within the American Society for Clinical Pharmacology and Therapeutics (ASCPT). His work has earned him several accolades, including the UCSF Discovery Fellowship and the Presidential Trainee Award from ASCPT for his research contributions.24

Personal Interests

Goswami is passionate about integrating advanced analytics and genomics into healthcare to improve patient outcomes. His vision for InsightRX is to leverage technology to minimize adverse drug events and enhance therapeutic success through informed dosing strategies.34

For more details, you can find him on LinkedIn under the username sirjgoswami.